Interest grows in scientific research on psilocybin microdosing, mental health

Canadian and international scientists are becoming more interested in researching how microdosing with psilocybin – the psychoactive substance in magic mushrooms – might be used to treat depression and other mental health concerns such as anxiety. University of Toronto Mississauga associate professor of psychology Norman Farb is launching a five-week study to examine how microdoses of psilocybin impacts people with low-grade anxiety and depression or persistent depressive disorder. “There is a re-emergence of interest and permission to start studying psychedelics,” said Farb. “There is a huge amount of private sector interest in psychedelic therapies as the next big investment opportunity in the health sector.” The article discusses how even though psilocybin is illegal in Canada, the public has shown a growing interest in using it to alleviate mental health concerns. CBC Note: Archived stories may contain dead links or be missing source links.